Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank100
3Y CAGR+10.8%
5Y CAGR+8.2%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+10.8%/yr
vs +89.8%/yr prior
5Y CAGR
+8.2%/yr
Consistent
Acceleration
-79.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44.33M | +9.7% |
| 2024 | $40.39M | +36.5% |
| 2023 | $29.58M | -9.3% |
| 2022 | $32.63M | +146.4% |
| 2021 | $13.24M | -55.8% |
| 2020 | $29.94M | +466.5% |
| 2019 | $5.29M | +110.3% |
| 2018 | $2.51M | +2493.0% |
| 2017 | $96915.00 | - |
| 2016 | $0.00 | - |